U.S. Oil and Gas Stock News

Aflac (NYSE:AFL) has introduced a hybrid term life and long term care rider aimed at aging U.S. consumers. The company is responding to growing long term care needs with a product that blends life insurance coverage and potential long term care benefits. Activist shareholder John Chevedden has filed a proposal urging Aflac to separate the Chairman and CEO roles. Aflac’s board is recommending shareholders vote against the governance proposal at the upcoming annual meeting. Aflac, trading...

RBC Capital has initiated coverage of Weatherford International (WFRD) with a positive view, citing peer leading cash generation, strong returns, and what it sees as an attractive valuation during current industry supply disruptions. See our latest analysis for Weatherford International. Weatherford International’s share price has been volatile recently, with a 9.63% 7 day share price return offsetting a 10.22% 30 day share price decline. Its 1 year total shareholder return of 78.30% and very...

If you are wondering whether West Pharmaceutical Services is priced fairly or carrying a premium, the recent share performance gives an important starting clue before looking at the numbers behind it. The stock last closed at US$248.12, with returns of 3.2% over 7 days, 1.1% over 30 days, a 10.2% decline year to date, and a 10.1% gain over 1 year. This combination paints a mixed picture of recent sentiment. Recent coverage on West Pharmaceutical Services has focused on its role in...

Crown Holdings (NYSE:CCK) has appointed Dr. John M. Rost as Executive Vice President and Chief Operating Officer, Asia Pacific and Transit Packaging. The company also received a shareholder proposal seeking the right for investors to act by written consent, ahead of its annual meeting. Crown Holdings, trading at $101.69, is drawing attention as it reshapes senior leadership around its Asia Pacific and Transit Packaging operations. The stock shows a 29.1% return over 3 years and a 14.5%...

GlobalFoundries has filed multiple patent infringement lawsuits against Tower Semiconductor (NasdaqGS:TSEM) in the U.S. International Trade Commission and District Court. The suits allege unauthorized use of critical manufacturing process technologies in Tower’s chip production. The legal actions introduce uncertainty around Tower’s ability to sell certain products into key markets if rulings or settlements are unfavorable. Tower Semiconductor, a specialty foundry player in analog and mixed...

Earlier this week, Globalstar reported record financial results and an upbeat revenue outlook for fiscal 2026, underpinned by its continuing global build-out of next-generation satellite ground infrastructure. The company’s positioning within the satellite communications ecosystem drew extra attention as reports of a potential SpaceX IPO lifted interest across space-related service providers. We’ll now examine how Globalstar’s record results and infrastructure expansion might influence its...

In recent days, Standex International reiterated its fiscal 2026 sales outlook and issued guidance for significantly higher revenue and improved operating margins for the third quarter of 2026, while analysts updated their models based on these refreshed assumptions. This combination of stronger guidance and refreshed analyst forecasts highlights how Standex’s mission-critical, higher-margin portfolio and disciplined cost controls are shaping expectations for its future earnings power. With...

Wondering whether Consolidated Edison at around US$111.52 is offering fair value or asking too much for its steady utility profile? This article walks through how that price compares with several common valuation checks. The share price has recently been fairly steady, with a 0.2% decline over the last 7 days, a 0.5% return over 30 days, 11.5% year to date, 6.8% over 1 year, 30.5% over 3 years, and 79.0% over 5 years. Recent attention on power grid resilience and regulated utilities as...

Why AptarGroup is on investors’ radar today AptarGroup (ATR) has attracted attention after recent share price moves, with a month return of about a 13% decline contrasting with a modest gain over the past 3 months. For investors tracking packaging and dispensing solution providers, AptarGroup’s current share price of $124.69 and market cap of about $8.1 billion provide a concrete snapshot of how the market is currently valuing its business. See our latest analysis for AptarGroup. The recent...

RBC Bearings, NYSE:RBC, has posted multi year revenue and earnings growth that has outpaced its industry peers. This performance highlights stronger operational execution and market share gains relative to competitors. The trend is drawing attention as investors reassess the company’s role within the broader industrial bearings sector. RBC Bearings is coming off a strong run in its share price, with the stock up 65.0% over the past year and 177.1% over the past five years. At a current...

U.S. officials have outlined plans for a voluntary investment consortium targeting up to $4 trillion for semiconductor, energy, and critical minerals supply chains. The initiative is expected to support U.S.-based technology and storage providers, including Seagate Technology Holdings (NasdaqGS:STX). The announcement focuses on long-term supply security for AI, chipmaking, and related infrastructure. For Seagate, a major provider of data storage solutions, this policy shift comes as demand...

Zscaler (NasdaqGS:ZS) has partnered with P0 Security to offer policy-driven Zero Trust authorization for both human and machine identities. The company has also integrated with Versa to automate SASE branch to cloud connectivity for distributed enterprises. These moves focus on securing cloud based and AI driven environments as organizations scale multi cloud and hybrid architectures. For investors watching Zscaler at a share price of $141.5, these product and partner moves come against a...

If you are wondering whether Ionis Pharmaceuticals at around US$74.24 is offering fair value or not, it helps to look past the headline price and focus on what different valuation tools are signaling. The stock has had a mixed recent run, with a 4.1% gain over the last 7 days, a 13.1% decline over 30 days and a 6.8% decline year to date, set against a 134.0% return over 1 year, 112.8% over 3 years and 64.8% over 5 years. Recent coverage has centered on Ionis Pharmaceuticals' role in the...

If you are wondering whether Belden at around US$113.98 is still a sensible entry point or has run ahead of itself, the key question is what you are actually paying for each dollar of the business. The stock has recently pulled back, with a 0.3% slip over the last week and a 23.0% decline over the past month, even though the 1 year return sits at 9.5% and the 5 year return at 158.4%. This mix of shorter term weakness and longer term strength often lines up with shifting views on growth...

If you are wondering whether Constellium's current share price lines up with its underlying value, the recent share performance offers a strong starting point for that question. The stock last closed at US$23.95, with returns of 1.0% over 7 days, a 3.2% decline over 30 days, 21.1% year to date, 120.3% over 1 year, 59.2% over 3 years and 61.0% over 5 years. This naturally raises questions about how much of the story is already in the price. Recent coverage of Constellium has focused on its...

Earlier in March 2026, Ally Financial was penalized by the SEC for failing to disclose that it profited from allocating a large portion of its robo-advisor client assets into cash-enhanced accounts, creating a conflict of interest around how those portfolios were constructed. This enforcement action raises broader questions about Ally’s transparency and compliance culture at a time when digital advisory services are increasingly central to its business model. We’ll now examine how this SEC...

In March 2026, reports indicated that OpenAI entered advanced talks with private equity firms including TPG, Advent International, Bain Capital, and Brookfield Asset Management to form a joint venture, potentially valued at about US$10.00 billion pre-money, to distribute its enterprise products across portfolio companies and other corporates. Under the proposal, TPG would act as anchor investor in a roughly US$4.00 billion-funded vehicle, gaining board representation, influence over how...

Liberty Energy Inc. recently completed a private offering of US$475.0 million zero-coupon convertible senior notes due March 1, 2032, upsized from an earlier US$450.0 million proposal and sold at 100% of principal under Rule 144A. The company plans to use the proceeds for capped call transactions and general corporate purposes, a structure that can affect future dilution and capital flexibility for existing shareholders. Next, we’ll examine how issuing zero-coupon convertible senior notes...

Assessing Penumbra after recent share performance Penumbra (PEN) has drawn attention after a mixed stretch for the stock, with a small move over the past week, a modest decline over the past month, and a positive total return over the past year. See our latest analysis for Penumbra. The current share price of $336.42 sits against a 90 day share price return of 6.14% and a 1 year total shareholder return of 24.78%, suggesting momentum has been building over the longer stretch. If Penumbra’s...

On March 13, 2026, William Blair reiterated its Outperform rating on Dave Inc after meeting with CFO Kyle Beilman, emphasizing the company’s data-driven, algorithmic, credit-first model and outlining ambitious 2026 plans centered on AI-driven innovation and new product launches. This renewed analyst confidence highlights how Dave’s focus on AI-powered credit decisioning and product expansion could influence perceptions of its longer-term revenue potential and business differentiation. Next,...

Why Crescent Energy Is On Investors’ Radar Crescent Energy (CRGY) has drawn fresh attention after a strong share price move over the past month. This has prompted investors to reassess its US$3.6b revenue base and current valuation signals. See our latest analysis for Crescent Energy. The recent 32.24% 1 month share price return and 65.58% 3 month share price return suggest momentum has picked up, while the 27.32% 1 year total shareholder return and 40.15% 3 year total shareholder return...

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has seen a significant 15% rise over the past year, with earnings expected to grow by 16% annually. In this context of fluctuating market conditions and promising growth forecasts, identifying high-growth tech stocks involves assessing their potential for innovation and scalability within this dynamic landscape.

Over the last 7 days, the United States market has dropped 1.6%, though it has risen by 15% over the past year, with earnings expected to grow by 16% per annum in the coming years. In this context of fluctuating short-term performance and positive long-term growth expectations, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.

Geron Corporation (NasdaqGS:GERN) has appointed Patricia S. Andrews and Constantine Chinoporos to its Board of Directors. Both appointees bring senior biopharmaceutical leadership experience across commercial operations, launches, and business development. The appointments come as Geron advances commercialization efforts for its key product, RYTELO. Geron focuses on hematologic oncology, with RYTELO positioned as a core asset in its portfolio. For investors, board changes at a company like...